These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4743174)

  • 1. [Resection of the liver in cirrhosis].
    Nartsissov TV
    Khirurgiia (Mosk); 1973 May; 49(5):79-84. PubMed ID: 4743174
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver resection in liver cirrhosis].
    Esser G
    Chirurg; 1979 Mar; 50(3):146-50. PubMed ID: 221160
    [No Abstract]   [Full Text] [Related]  

  • 3. [The value of echotomography in the planning of surgical treatment of liver cirrhosis].
    Akhundzhanov BA; Mel'kumov RS; Dusmuratov AM; Dadaev KhA; Akhundzhanov MB; Dadaev ShA
    Sov Med; 1990; (3):86-9. PubMed ID: 2195674
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental basis for cryogenic and laser destruction of a part of the cirrhotic liver for stimulating regenerative processes].
    Martynov AIu; Kaĭgorodova NV
    Vestn Khir Im I I Grek; 1979 Dec; 123(12):29-33. PubMed ID: 524681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of liver cirrhosis with the use of regeneration stimulators].
    Akhundzhanov BA
    Khirurgiia (Mosk); 1976 Jan; (1):34-8. PubMed ID: 56476
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of portal venous pressure is useful for selecting the optimal type of resection in cirrhotic patients with hepatocellular carcinoma.
    Kanematsu T; Furui J; Yanaga K; Okudaira S; Kamohara Y; Eguchi S
    Hepatogastroenterology; 2005; 52(66):1828-31. PubMed ID: 16334786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Marginal resection of the liver in advanced chronic hepatitis and liver cirrhosis].
    Ardamatskaia AN
    Vestn Khir Im I I Grek; 1973 Jun; 110(6):32-5. PubMed ID: 4773396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
    Chen XP; Wu ZD; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Focal cirrhosis of the liver].
    Pyshkin SA; Borisov DL; Gorfinkel' AN; Efremova EV; Iuskin IA
    Khirurgiia (Mosk); 2005; (10):46-9. PubMed ID: 16247407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatic resection and hepatic arterial chemoembolization for primary liver carcinoma].
    Hu Y; Chen D
    Zhonghua Wai Ke Za Zhi; 1997 Sep; 35(9):536-8. PubMed ID: 10678026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic resection for hepatocarcinoma in the cirrhotic patient].
    Chiappa A; Zbar AP; Bertani E; Biella F; Staudacher C
    Chir Ital; 1999; 51(5):345-54. PubMed ID: 10738607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of the shunt indication in patients with portal hypertension].
    Bucher H; Fuchs WA; Tauber J; Rösler H; Preisig R
    Schweiz Med Wochenschr; 1969 Feb; 99(7):229-38. PubMed ID: 5769267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum arginase activity in patients with liver cirrhosis and hepatocellular carcinoma].
    Chrzanowska A; Mielczarek-Puta M; Skwarek A; Krawczyk M; Barańczyk-Kuźma A
    Wiad Lek; 2007; 60(5-6):215-8. PubMed ID: 17966882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature].
    Neeff H; Makowiec F; Harder J; Gumpp V; Klock A; Thimme R; Drognitz O; Hopt UT
    Zentralbl Chir; 2009 Apr; 134(2):127-35. PubMed ID: 19382043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.
    Takada Y; Otsuka M; Todoroki T; Fukao K
    Hepatogastroenterology; 2003; 50(54):1991-5. PubMed ID: 14696450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is hepatic resection absolutely contraindicated for hepatocellular carcinoma in Child-Pugh class C cirrhotic patients?
    Wu CC; Ho WL; Lin MC; Tang JS; Yeh DC; Liu TJ; P'eng FK
    Hepatogastroenterology; 1999; 46(26):635-9. PubMed ID: 10370588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
    Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
    Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Approaches of preoperative assessment of liver function in cirrhotic patient: current status and future prospects].
    Mao YL; Zhang T
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):849-52. PubMed ID: 17260481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice.
    Das BC; Isaji S; Kawarada Y
    World J Surg; 2001 Mar; 25(3):266-72; discussion 272-3. PubMed ID: 11343174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.